Skip to content

PHARMACIE HAMPERT: what changed

BE 0833.026.694NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€92,740
2024 · €55,747+€36,993
Equity
€269,049
2024 · €283,432-€14,384
Cash
€360,352
2024 · €261,482+€98,871
Balance sheet total
€613,656
2024 · €441,721+€171,935

Largest movements

2024 to 2025
Assets
  • Cash +€98,871

    up €98,871 (+37.8%), from €261,482 to €360,352

    mainly Other debts (+€109,934) and Net result for the year (+€92,740)

  • Receivables within one year +€52,228

    up €52,228 (+79.6%), from €65,578 to €117,806

    of which Trade receivables: +€55,080

  • Stocks and contracts +€28,562

    up €28,562 (+31.9%), from €89,402 to €117,964

  • Tangible fixed assets -€9,085

    down €9,085 (-41.5%), from €21,908 to €12,824

    of which Furniture and vehicles: -€6,021

Equity and liabilities
  • Other debts +€109,934

    up €109,934 (+95.4%), from €115,202 to €225,135

  • Trade debts +€54,151

    up €54,151 (+189%), from €28,583 to €82,733

  • Tax, wage and social debts +€22,234

    up €22,234 (+153%), from €14,505 to €36,739

    of which Taxes: +€20,221

  • Reserves -€14,384

    down €14,384 (-5.5%), from €260,000 to €245,616

Income statement
  • Gross operating margin +€66,999

    up €66,999 (+52.8%), from €126,935 to €193,933

  • Staff costs +€15,454

    up €15,454 (+45.0%), from €34,309 to €49,762

  • Taxes +€13,289

    up €13,289 (+60.5%), from €21,972 to €35,261

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €55,747
Gross operating margin +€66,999
Staff costs -€15,454
Depreciation -€93
Other operating charges +€4
Financial income -€308
Financial charges -€867
Taxes -€13,289
Result 2025 €92,740
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€205,994
Investment €0
Financing -€107,123
Cash 2024 €261,482
Net result for the year +€92,740
Depreciation +€9,085
Stocks and contracts -€28,562
Receivables within one year -€52,228
Deferred charges and accrued income -€1,359
Trade debts +€54,151
Tax, wage and social debts +€22,234
Other debts +€109,934
Contributions, distributions and other -€107,123
Cash 2025 €360,352
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €441,721 €613,656 +€171,935 +38.9%
Fixed assets 21/28 €22,711 €13,627 -€9,085 -40.0%
Tangible fixed assets 22/27 €21,908 €12,824 -€9,085 -41.5%
Plant, machinery and equipment 23 €11,496 €8,433 -€3,064 -26.6%
Furniture and vehicles 24 €10,412 €4,391 -€6,021 -57.8%
Financial fixed assets 28 €803 €803 = 0.0%
Current assets 29/58 €419,010 €600,029 +€181,020 +43.2%
Stocks and contracts in progress 3 €89,402 €117,964 +€28,562 +31.9%
Stocks 30/36 €89,402 €117,964 +€28,562 +31.9%
Amounts receivable within one year 40/41 €65,578 €117,806 +€52,228 +79.6%
Trade receivables 40 €61,201 €116,280 +€55,080 +90.0%
Other amounts receivable 41 €4,378 €1,526 -€2,851 -65.1%
Cash at bank and in hand 54/58 €261,482 €360,352 +€98,871 +37.8%
Deferred charges and accrued income 490/1 €2,547 €3,907 +€1,359 +53.4%
Total equity and liabilities 10/49 €441,721 €613,656 +€171,935 +38.9%
Equity 10/15 €283,432 €269,049 -€14,384 -5.1%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €260,000 €245,616 -€14,384 -5.5%
Distributable reserves 133 €260,000 €245,616 -€14,384 -5.5%
Profit (loss) carried forward 14 €4,832 €4,832 = 0.0%
Amounts payable 17/49 €158,289 €344,607 +€186,319 +118%
Amounts payable within one year 42/48 €158,289 €344,607 +€186,319 +118%
Trade debts 44 €28,583 €82,733 +€54,151 +189%
Suppliers 440/4 €28,583 €82,733 +€54,151 +189%
Taxes, remuneration and social security 45 €14,505 €36,739 +€22,234 +153%
Taxes 450/3 €7,058 €27,279 +€20,221 +286%
Remuneration and social security 454/9 €7,446 €9,460 +€2,014 +27.0%
Other amounts payable 47/48 €115,202 €225,135 +€109,934 +95.4%
Remuneration, social security and pensions 62 €34,309 €49,762 +€15,454 +45.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,992 €9,085 +€93 +1.0%
Other operating charges 640/8 €21 €16 -€4 -20.6%
Gross operating margin 9900 €126,935 €193,933 +€66,999 +52.8%
Operating profit (loss) 9901 €83,614 €135,070 +€51,456 +61.5%
Financial income 75/76B €1,720 €1,411 -€308 -17.9%
Recurring financial income 75 €1,720 €1,411 -€308 -17.9%
Financial charges 65/66B €7,615 €8,481 +€867 +11.4%
Recurring financial charges 65 €7,615 €8,481 +€867 +11.4%
Profit (loss) for the period before taxes 9903 €77,719 €128,000 +€50,282 +64.7%
Income taxes 67/77 €21,972 €35,261 +€13,289 +60.5%
Profit (loss) for the period 9904 €55,747 €92,740 +€36,993 +66.4%
Profit (loss) for the period to be appropriated 9905 €55,747 €92,740 +€36,993 +66.4%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€387,774 to €489,074

Midpoint €429,983 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €269,049
Capitalised earnings €506,500 to €709,100
Indication €387,774 to €489,074

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€269,049
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€269,049

Capitalised earnings

net result for the year (9904)
2025
€92,740
2024
€55,747
2023
€64,243
2022
€36,123
2021
€36,485
Average result
€70,910
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€506,500 / €590,917 / €709,100

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 15 November 2026 via checked.be.